| 标题 |
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood Journal 作者:Maximilian F. Stahl; Amer M. Zeidan 出版日期:2025 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |